- Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis2023 | Faculty of Physical Education and Sport
- Significantly lower relapse rate for TEL/AML1-positive ALL1999 | Second Faculty of Medicine
- Is three mont treatment with cyclophosphamide sufficiency effective in decreasing the relapse rate in ANCA-positive renal vasculitis?2003 | First Faculty of Medicine
- Intracellular Cytokine Production in ANCA-associated Vasculitis: Low Levels of Interleukin-10 in Remission Are Associated with a Higher Relapse Rate in the Long-term Follow-up2009 | First Faculty of Medicine
- Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience2017 | First Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 | First Faculty of Medicine
- Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis2017 | First Faculty of Medicine
- Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis2012 | First Faculty of Medicine
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | First Faculty of Medicine, Second Faculty of Medicine
- Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study2009 | First Faculty of Medicine
- Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients2020 | Second Faculty of Medicine
- Pregnancy and multiple sclerosis -outcomes analysis 2003-20112013 | Second Faculty of Medicine
- A comparison of efficacy of subcutaneous interferon beta-1a 44 mu g, dimethyl fumarate and fingolimod in the real-life clinical practise - a multicenter observational study2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission A Randomized Clinical Trial2010 | First Faculty of Medicine
- Effect of subcutaneously administered interferon β-1a on disease activity in patients with clinically isolated syndrome - ATRACT observational study2019 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Family Psychoeducaton Following First Epizode Schizophrenia2001 | Publication without faculty affiliation
- Multiple Sclerosis Relapses Following Cessation of Fingolimod2022 | First Faculty of Medicine
- Desmopressin in a long-term treatment of children with primary nocturnal enuresis - a symptomatic therapy?2001 | Second Faculty of Medicine
- Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)2014 | Second Faculty of Medicine
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis2010 | Second Faculty of Medicine
- Long-term therapy of multiple sclerosis with fingolimod - results of 4.5-year extension study to TRANSFORMS2016 | Publication without faculty affiliation
- The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT2013 | First Faculty of Medicine
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis2015 | First Faculty of Medicine
- Relapse prevention in schizophrenia: does group family psychoeducation matter? One-year prospective follow-up field study2006 | Publication without faculty affiliation
- Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol2016 | Second Faculty of Medicine
- Role of Helicobacter pylori in pathogenesis and therapy of peptic ulcer disease2004 | First Faculty of Medicine
- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study2017 | First Faculty of Medicine
- Aripiprazole in the form of long-acting intramuscular injections2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | Second Faculty of Medicine
- Information Technology Aided RElapse Prevention in Schizophrenia2007 | Publication without faculty affiliation